药品注册申请号:022207
申请类型:NDA (新药申请)
申请人:HIKMA
申请人全名:HIKMA PHARMACEUTICALS INTERNATIONAL LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 15MG Yes No AB 2008/03/17 2008/03/17 Prescription
002 MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 30MG Yes Yes AB 2008/03/17 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/10/31 SUPPL-13(补充) Approval REMS N/A
2023/12/15 SUPPL-11(补充) Approval Labeling STANDARD
2021/06/02 SUPPL-5(补充) Approval Efficacy STANDARD
2021/03/04 SUPPL-10(补充) Approval Labeling STANDARD
2019/10/07 SUPPL-9(补充) Approval Labeling STANDARD
2018/09/18 SUPPL-8(补充) Approval Labeling STANDARD
2018/09/18 SUPPL-7(补充) Approval REMS N/A
2016/12/16 SUPPL-6(补充) Approval Labeling STANDARD
2012/01/23 SUPPL-4(补充) Approval Labeling UNKNOWN
2010/04/15 SUPPL-2(补充) Approval Labeling UNKNOWN
2008/03/17 ORIG-1(原始申请) Approval Type 7 - Drug Already Marketed without Approved NDA STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
001 NPP 2024/06/02
002 NPP 2024/06/02
与本品治疗等效的药品
活性成分:MORPHINE SULFATE 剂型/给药途径:TABLET;ORAL 规格:15MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022207 001 NDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 15MG Prescription Yes No AB 2008/03/17 HIKMA
210610 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 15MG Prescription No No AB 2019/07/22 UPSHER SMITH LABS
212451 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 15MG Prescription No No AB 2020/12/03 ALKEM LABS LTD
207270 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 15MG Discontinued No No AB 2022/01/12 DR REDDYS LABS SA
215194 001 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 15MG Prescription No No AB 2023/08/21 SPECGX LLC
活性成分:MORPHINE SULFATE 剂型/给药途径:TABLET;ORAL 规格:30MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
022207 002 NDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 30MG Prescription Yes Yes AB 2008/03/17 HIKMA
210610 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 30MG Prescription No No AB 2019/07/22 UPSHER SMITH LABS
212451 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 30MG Prescription No No AB 2020/12/03 ALKEM LABS LTD
207270 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 30MG Discontinued No No AB 2022/01/12 DR REDDYS LABS SA
215194 002 ANDA MORPHINE SULFATE MORPHINE SULFATE TABLET;ORAL 30MG Prescription No No AB 2023/08/21 SPECGX LLC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database